Topics

Human medicines European public assessment report (EPAR): Rotarix, rotavirus vaccine, live, attenuated, Immunization,Rotavirus Infections, Date of authorisation: 21/02/2006, Revision: 31, Status: Authorised

11:00 EDT 14 Aug 2019 | European Medicines Agency

Human medicines European public assessment report (EPAR): Rotarix, rotavirus vaccine, live, attenuated, Immunization,Rotavirus Infections, Date of authorisation: 21/02/2006, Revision: 31, Status: Authorised

Original Article: Human medicines European public assessment report (EPAR): Rotarix, rotavirus vaccine, live, attenuated, Immunization,Rotavirus Infections, Date of authorisation: 21/02/2006, Revision: 31, Status: Authorised

NEXT ARTICLE

More From BioPortfolio on "Human medicines European public assessment report (EPAR): Rotarix, rotavirus vaccine, live, attenuated, Immunization,Rotavirus Infections, Date of authorisation: 21/02/2006, Revision: 31, Status: Authorised"

Quick Search

Relevant Topic

Immunology
Allergies Automimmune Disease Human Papillomavirus (HPV) Immunology Vaccine Immunology is the study of immunity and the defence mechanisms of the body. A greater understanding of immunology is needed to develop vaccines, understand ...